Bulletin
Investor Alert

Illumina Inc.

NAS: ILMN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Illumina Inc.

After Hours

 --Quotes are delayed by 20 min

Mar 31, 2023, 7:58 p.m.

ILMN
/zigman2/quotes/203509482/composite

$

232.80

Change

+0.25 +0.11%

Volume

Volume 59,400

Quotes are delayed by 20 min

/zigman2/quotes/203509482/composite

Previous close

$ 225.26

$ 232.55

Change

+7.29 +3.24%

Day low

Day high

$225.65

$232.81

Open

52 week low

52 week high

$173.45

$371.16

Open

Company Description

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields,...

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Valuation

Price to Sales Ratio

6.93

Price to Book Ratio

4.84

Price to Cash Flow Ratio

79.36

Enterprise Value to EBITDA

49.61

Enterprise Value to Sales

8.10

Total Debt to Enterprise Value

0.11

Efficiency

Revenue/Employee

398,609.00

Income Per Employee

-382,957.00

Receivables Turnover

6.78

Total Asset Turnover

0.33

Liquidity

Current Ratio

1.28

Quick Ratio

1.08

Cash Ratio

0.73

Profitability

Gross Margin

64.83

Operating Margin

7.72

Pretax Margin

-94.59

Net Margin

-96.07

Return on Assets

-32.07

Return on Equity

-50.80

Return on Total Capital

3.02

Return on Invested Capital

-39.97

Capital Structure

Total Debt to Total Equity

53.87

Total Debt to Total Capital

35.01

Total Debt to Total Assets

29.02

Long-Term Debt to Equity

33.81

Long-Term Debt to Total Capital

21.97

Officers and Executives

Name Age Officer Since Title
Mr. Francis A. deSouza 48 2013 President
Mr. Kevin Pegels - 2021 Chief-Global Operations
Dr. Joydeep Goswami 48 2019 SVP-Corporate Development & Strategic Planning
Dr. Alex Aravanis - 2020 Chief Technology Officer & Senior Vice President
Ms. Carissa Rollins - 2022 Chief Information Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/22/2023 Alex Aravanis
SVP, Chief Technology Officer 		2,320   Disposition at $202.16 per share. 469,011
02/22/2023 Alex Aravanis
SVP, Chief Technology Officer 		3,078   Disposition at $201.42 per share. 619,970
02/21/2023 Francis A. deSouza
President and CEO; Director 		10,907   Derivative/Non-derivative trans. at $202.84 per share. 2,212,375
02/21/2023 Susan H. Tousi
SVP, Chief Commercial Officer 		2,197   Derivative/Non-derivative trans. at $202.84 per share. 445,639
02/21/2023 Joydeep Goswami
SVP Chief Financial Officer 		1,640   Derivative/Non-derivative trans. at $202.84 per share. 332,657
02/21/2023 Charles E. Dadswell
SVP & General Counsel 		1,907   Derivative/Non-derivative trans. at $202.84 per share. 386,815
02/21/2023 Phillip G. Febbo
SVP Chief Medical Officer 		1,245   Derivative/Non-derivative trans. at $202.84 per share. 252,535
02/21/2023 Kevin Pegels
Chief of Global Operations 		409   Derivative/Non-derivative trans. at $202.84 per share. 82,961
02/21/2023 Aimee Hoyt
SVP, Chief People Officer 		1,365   Derivative/Non-derivative trans. at $202.84 per share. 276,876
02/21/2023 Kathryne Reeves
SVP, Chief Marketing Officer 		704   Derivative/Non-derivative trans. at $202.84 per share. 142,799
02/21/2023 Alex Aravanis
SVP, Chief Technology Officer 		3,894   Derivative/Non-derivative trans. at $202.84 per share. 789,858
02/21/2023 Francis A. deSouza
President and CEO; Director 		23,473   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Susan H. Tousi
SVP, Chief Commercial Officer 		5,869   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Joydeep Goswami
SVP Chief Financial Officer 		4,696   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Charles E. Dadswell
SVP & General Counsel 		5,282   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Phillip G. Febbo
SVP Chief Medical Officer 		3,522   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Kevin Pegels
Chief of Global Operations 		1,097   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Aimee Hoyt
SVP, Chief People Officer 		5,282   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Kathryne Reeves
SVP, Chief Marketing Officer 		2,789   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Alex Aravanis
SVP, Chief Technology Officer 		9,292   Derivative/Non-derivative trans. at $0 per share. 0
02/06/2023 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $211.57 per share. 105,785
01/09/2023 Aimee Hoyt
SVP, Chief People Officer 		871   Disposition at $205.57 per share. 179,051
01/06/2023 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $204.58 per share. 102,290
12/06/2022 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $212.63 per share. 106,315
11/08/2022 Alex Aravanis
SVP, Chief Technology Officer 		361   Disposition at $218 per share. 78,698
11/07/2022 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $223.65 per share. 111,825
11/07/2022 Aimee Hoyt
SVP, Chief People Officer 		1,045   Disposition at $223.65 per share. 233,714
11/07/2022 Aimee Hoyt
SVP, Chief People Officer 		1,294   Disposition at $223.65 per share. 289,403
11/05/2022 Francis A. deSouza
President and CEO; Director 		2,591   Derivative/Non-derivative trans. at $217.19 per share. 562,739
11/05/2022 Susan H. Tousi
SVP, Chief Commercial Officer 		721   Derivative/Non-derivative trans. at $217.19 per share. 156,593
11/05/2022 Joydeep Goswami
SVP Chief Financial Officer 		638   Derivative/Non-derivative trans. at $217.19 per share. 138,567
11/05/2022 Charles E. Dadswell
SVP & General Counsel 		853   Derivative/Non-derivative trans. at $217.19 per share. 185,263
11/05/2022 Phillip G. Febbo
SVP Chief Medical Officer 		821   Derivative/Non-derivative trans. at $217.19 per share. 178,312
11/05/2022 Kevin Pegels
Chief of Global Operations 		472   Derivative/Non-derivative trans. at $217.19 per share. 102,513
11/05/2022 Aimee Hoyt
SVP, Chief People Officer 		640   Derivative/Non-derivative trans. at $217.19 per share. 139,001
11/05/2022 Scott Ericksen
VP, Chief Accounting Officer 		213   Derivative/Non-derivative trans. at $217.19 per share. 46,261
11/05/2022 Kathryne Reeves
SVP, Chief Marketing Officer 		212   Derivative/Non-derivative trans. at $217.19 per share. 46,044
11/05/2022 Alex Aravanis
SVP, Chief Technology Officer 		191   Derivative/Non-derivative trans. at $217.19 per share. 41,483
10/06/2022 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $216.59 per share. 108,295
/news/latest/company/us/ilmn

MarketWatch News on ILMN

  2. Illumina Inc. stock outperforms competitors on strong trading day

    5:03 p.m. March 31, 2023

    - MarketWatch Automation

  3. Illumina Inc. stock outperforms market on strong trading day

    5:01 p.m. March 30, 2023

    - MarketWatch Automation

  4. Illumina Inc. stock outperforms competitors on strong trading day

    5:01 p.m. March 29, 2023

    - MarketWatch Automation

  5. Carl Icahn tells WSJ he wants old CEO back at Illumina

    8:08 a.m. March 29, 2023

    - Steve Gelsi

  6. Illumina Inc. stock falls Tuesday, underperforms market

    5:01 p.m. March 28, 2023

    - MarketWatch Automation

  7. Illumina Inc. stock falls Monday, underperforms market

    5:01 p.m. March 27, 2023

    - MarketWatch Automation

  8. Illumina Inc. stock rises Friday, outperforms market

    5:01 p.m. March 24, 2023

    - MarketWatch Automation

  9. Illumina Inc. stock falls Thursday, underperforms market

    5:01 p.m. March 23, 2023

    - MarketWatch Automation

  10. Illumina Inc. stock falls Wednesday, underperforms market

    5:01 p.m. March 22, 2023

    - MarketWatch Automation

  11. Illumina Inc. stock rises Tuesday, still underperforms market

    5:01 p.m. March 21, 2023

    - MarketWatch Automation

  12. Illumina Inc. stock underperforms Monday when compared to competitors

    5:01 p.m. March 20, 2023

    - MarketWatch Automation

  13. A Tonic for Market Turmoil: Consumer Staples

    9:31 p.m. March 17, 2023

    - Barron's Online

  14. Illumina Inc. stock outperforms market despite losses on the day

    5:01 p.m. March 17, 2023

    - MarketWatch Automation

  15. Illumina Inc. stock underperforms Thursday when compared to competitors

    5:01 p.m. March 16, 2023

    - MarketWatch Automation

  16. Illumina Inc. stock rises Wednesday, outperforms market

    5:01 p.m. March 15, 2023

    - MarketWatch Automation

  17. Illumina Inc. stock falls Tuesday, underperforms market

    5:02 p.m. March 14, 2023

    - MarketWatch Automation

  18. SVB May Be a Failure of Supervision. What It Means for Other Banks.

    6:47 a.m. March 14, 2023

    - Barron's Online

  19. Illumina Inc. stock rises Monday, outperforms market

    5:02 p.m. March 13, 2023

    - MarketWatch Automation

  21. Loading more headlines...
/news/nonmarketwatch/company/us/ilmn

Other News on ILMN

  1. Carl Icahn Wants to Bring Illumina’s Old CEO Back

    1:49 p.m. March 29, 2023

    - David Wainer

  2. Illumina Should Heed Icahn, Give Up on Holy Grail

    2:31 p.m. March 17, 2023

    - David Wainer

  3. Carl Icahn Responds to Illumina in Open Letter

    5:03 p.m. March 16, 2023

    - GuruFocus.com

  4. Carl Icahn Pens Open Letter to Illumina Shareholders

    2:50 p.m. March 13, 2023

    - GuruFocus.com

  5. Carl Icahn Prepares for Proxy Fight at Illumina

    10:50 p.m. March 12, 2023

    - Lauren Thomas

  6. The FTC’s Antitrust Collusion

    6:36 p.m. Feb. 23, 2023

    - The Editorial Board

  7. Startups Take On Illumina in Race for Cheaper DNA Sequencing

    2:35 p.m. Feb. 16, 2023

    - Brian Gormley

  8. Top 5 4th Quarter Trades of MayTech Global Investments, LLC

    2:00 p.m. Feb. 16, 2023

    - GuruFocus.com

  9. Stocks Rise as Investors Await Inflation Data

    5:01 p.m. Feb. 13, 2023

    - Caitlin Ostroff

  10. Top 5 4th Quarter Trades of SECTOR GAMMA AS

    2:00 p.m. Feb. 8, 2023

    - GuruFocus.com

  11. SECTOR GAMMA AS Buys 3, Sells 2 in 4th Quarter

    10:00 a.m. Feb. 7, 2023

    - GuruFocus.com

  12. Lina Khan Chalks Up Another Defeat

    6:41 p.m. Feb. 6, 2023

    - The Editorial Board

  13. The FTC Can’t See the Future

    5:02 p.m. Feb. 5, 2023

    - Andy Kessler

  14. Illumina Makes Its Interim CFO Permanent

    9:15 a.m. Feb. 1, 2023

    - Kristin Broughton

  15. Baillie Gifford Slashes Meta, Boosts Nvidia

    5:11 p.m. Jan. 25, 2023

    - GuruFocus.com

  16. Top 5 4th Quarter Trades of Amazon com Inc

    6:00 p.m. Jan. 18, 2023

    - GuruFocus.com

  17. STONNINGTON GROUP, LLC Buys 2, Sells 3 in 4th Quarter

    6:00 p.m. Jan. 11, 2023

    - GuruFocus.com

  18. Aurora Investment Managers, LLC. Buys 3, Sells 2 in 4th Quarter

    4:00 p.m. Jan. 11, 2023

    - GuruFocus.com

  20. Illumina: A Growth Stock in Waiting

    10:13 a.m. Jan. 4, 2023

    - GuruFocus.com

  21. Loading more headlines...

At a Glance

Illumina, Inc.

5200 Illumina Way

San Diego, California 92122

Phone

1 8582024500

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2023

View SEC Filings

Revenue

$4.58B

Net Income

$-4.40B

2022 Sales Growth

1.3%

Employees

11,500

Annual Report for ILMN

/news/pressrelease/company/us/ilmn

Press Releases on ILMN

  2. DNA Data Storage Alliance Announces Board Appointments

    8:00 a.m. March 29, 2023

    - BusinessWire - BZX

  3. When Illumina ($ILMN) Moves Investors should Listen

    10:31 a.m. March 28, 2023

    - Stock Traders Daily

  12. Illumina Responds to Icahn Partners' Nomination of Directors

    1:48 p.m. March 13, 2023

    - PR Newswire - PRF

  13. Nasdaq 100 Movers: FISV, SGEN

    10:41 a.m. March 13, 2023

    - MarketNewsVideo.com

  14. S&P 500 Movers: FRC, ILMN

    10:39 a.m. March 13, 2023

    - MarketNewsVideo.com

  17. Trend Tracker for Illumina $ILMN

    4:49 a.m. March 9, 2023

    - Stock Traders Daily

  21. Loading more headlines...
Link to MarketWatch's Slice.